前沿生物-U
(688221)
| 流通市值：51.02亿 | | | 总市值：51.02亿 |
| 流通股本：3.75亿 | | | 总股本：3.75亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 337,820,322.94 | 313,296,180.72 | 297,131,734.61 | 123,386,656.86 |
| 营业总成本 | 286,099,609.23 | 179,728,405.4 | 74,623,130.61 | 378,879,481.97 |
| 其他经营收益 | | | | |
| 营业利润 | 72,489,585.12 | 148,964,338.45 | 227,645,045.69 | -267,720,614.09 |
| 利润总额 | 72,437,200.35 | 148,929,627.03 | 227,393,754.18 | -268,053,032.03 |
| 净利润 | 72,437,186.14 | 148,929,627.03 | 227,393,754.18 | -268,053,032.03 |
| 每股收益 | | | | |
| 其他综合收益 | 104,159.39 | 78,596.2 | 40,776.3 | 15,381.27 |
| 综合收益总额 | 72,541,345.53 | 149,008,223.23 | 227,434,530.48 | -268,037,650.76 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,085,423,507.92 | 1,193,547,073.21 | 1,287,817,815.85 | 1,004,818,169.9 |
| 非流动资产: | | | | |
| 非流动资产合计 | 545,849,962.39 | 552,036,755.04 | 562,633,115.57 | 573,492,344.21 |
| 资产总计 | 1,631,273,470.31 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 |
| 流动负债: | | | | |
| 流动负债合计 | 195,796,507.73 | 240,798,092.39 | 363,781,884.82 | 410,339,338.82 |
| 非流动负债: | | | | |
| 非流动负债合计 | 474,010,683.89 | 470,915,454.88 | 378,391,172.08 | 291,102,383.29 |
| 负债合计 | 669,807,191.62 | 711,713,547.27 | 742,173,056.9 | 701,441,722.11 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 961,466,278.69 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 |
| 股东权益合计 | 961,466,278.69 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 |
| 负债和股东权益合计 | 1,631,273,470.31 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 411,481,779.65 | 381,894,352.02 | 328,879,067.99 | 119,691,620.15 |
| 经营活动现金流出小计 | 284,990,403.02 | 201,005,386.4 | 110,999,278.73 | 346,279,922.92 |
| 经营活动产生的现金流量净额 | 126,491,376.63 | 180,888,965.62 | 217,879,789.26 | -226,588,302.77 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,871,831,416.51 | 1,350,289,913.66 | 651,741,137.27 | 3,013,117,222.18 |
| 投资活动现金流出小计 | 1,990,895,090.43 | 1,313,844,888.43 | 912,280,941.05 | 2,840,434,170.78 |
| 投资活动产生的现金流量净额 | -119,063,673.92 | 36,445,025.23 | -260,539,803.78 | 172,683,051.4 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 251,658,756.4 | 242,258,756.4 | 142,258,756.4 | 361,850,023.44 |
| 筹资活动现金流出小计 | 292,706,253.98 | 236,767,285.25 | 82,281,460.41 | 386,272,934.27 |
| 筹资活动产生的现金流量净额 | -41,047,497.58 | 5,491,471.15 | 59,977,295.99 | -24,422,910.83 |
| 汇率变动对现金及现金等价物的影响 | -329,438.47 | 57,156.55 | -60,241.86 | -47,436.25 |
| 现金及现金等价物净增加额 | -33,949,233.34 | 222,882,618.55 | 17,257,039.61 | -78,375,598.45 |
| 期末现金及现金等价物余额 | 136,395,126.03 | 393,226,977.92 | 187,601,398.98 | 170,344,359.37 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 222,882,618.55 | - | -78,375,598.45 |
最新报告期：2026-09-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国联民生 | 张金洋,胡偌碧,郭广洋 | 0.07 | -0.26 | -0.24 | 2026-09-03 |
| 开源证券 | 余汝意,巢舒然 | -0.08 | -0.51 | -0.57 | 2026-09-01 |